Exchange: NASDAQ·Updated 04:53 AM EDT

ABIO ARCA biopharma Inc

$91.30
$0.31
(0.34%)
Pre-Market
Prev Close $90.99
Mkt Cap$6.07B
Vol181.00

About ABIO

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
65

Bullish Sentiment

How do you feel about ABIO?

Advertisement|Remove ads.